Enstilar with Enbrel or Humira for Plaque Psoriasis
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Psoriasis Treatment Center of Central New Jersey · Other
This trial is looking for adults aged 18 or older who have chronic plaque psoriasis. Participants must have a specific level of skin involvement and have been on certain treatments for at least 24 weeks.
You may be able to join if
- I am 18 years old or older
- I have chronic plaque-type psoriasis
- I have 2-10% body surface area affected
- My Physician Global Assessment score is 2 or greater
- I have been treated with Enbrel or Humira for at least 24 weeks
You may not be able to join if
- I have less than 2% or more than 10% body surface area affected
- My Physician Global Assessment score is less than 2
- I am not receiving Enbrel or Humira
- I have been receiving Enbrel or Humira for less than 24 weeks
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility4 weeks of adjunctive therapy of Enstilar® QD followed by 12 weeks QOD to patients with 2-10% BSA who are receiving etanercept or adalimumab for at least 24 weeks
Loading trial locations…